| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 67.5617 | 68 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.3427 | 46 |
| GSM780709 | Untreated after 4 days (C3_1) | 54.1544 | 58 |
| GSM780719 | Untreated after 4 days (C1_2) | 66.6183 | 68 |
| GSM780720 | Untreated after 4 days (C2_2) | 60.0579 | 64 |
| GSM780721 | Untreated after 4 days (C3_2) | 57.1186 | 62 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.813 | 44 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 63.9904 | 67 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 60.9855 | 65 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.5654 | 50 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 66.4055 | 68 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 59.7098 | 64 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 69.8669 | 69 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 52.5519 | 55 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 65.645 | 67 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 69.0057 | 69 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 59.1511 | 64 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 61.0867 | 65 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 68.9724 | 69 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 64.1625 | 67 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 55.5971 | 60 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 64.6169 | 67 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 61.4105 | 65 |